As presented in Supplementary Figure 10, HCC patients with high expression levels of KPNA2, KIF2C, SPP1, and LPCAT1 and low expression of FMO3 exhibited a poor clinical prognosis of OS and RFS. Here, FMO3 is linked to hepatocellular carcinoma.